Consequently, miR-326 acts as a negative regulator of CD155 expression in lung adenocarcinoma, and as a result, it may have a role in the emergence of resistance to PD-1/PD-L1 inhibitors [181]. Here, CD274 is linked to lung adenocarcinoma.